TROPION-PanTumor03, a phase 2, multicentre study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients with advanced/metastatic solid tumours: Substudies in gastric and colorectal cancer Meeting Abstract


Authors: Oaknin, A.; Meric-Bernstam, F.; Lang, J.; Ciombor, K.; Ray-Coquard, I.; Oza, A.; Yonemori, K.; Xu, R.; Zhao, J.; Gajavelli, S.; Filant, J.; Hovey, T.; Janjigian, Y.
Abstract Title: TROPION-PanTumor03, a phase 2, multicentre study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients with advanced/metastatic solid tumours: Substudies in gastric and colorectal cancer
Meeting Title: 25th World Congress on Gastrointestinal Cancer (ESMO 2023)
Keywords: oncology
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 1
Meeting Dates: 2023 Jun 28-Jul 1
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-06-01
Start Page: S59
End Page: S60
Language: English
ACCESSION: WOS:001037960400127
DOI: 10.1016/j.annonc.2023.04.182
PROVIDER: wos
Notes: Meeting Abstract: P-126 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yelena Yuriy Janjigian
    394 Janjigian